TECX
Tectonic TherapeuticDNasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-07-20
+
Peers tracked
11
U.S. public peers
Grade Position
Below peers
vs peer average
TECX vs peer average
19/100
TECX vs. peer average (D vs. B)
Grade spread
A 4 · B 4 · C 2 · F 1
Graded peers loaded
Coverage
11 graded
100% of tracked
Peer overview
CTNM is the first available peer comparator.
Contineum is a similarly sized clinical-stage biotech where valuation is driven mainly by readout timing and balance-sheet durability rather than current revenue, making it a reasonable event-risk comp despite different biology.
✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
TECX
Tectonic Therapeutic
CTNM
Contineum Therapeutics
Grade
D
C
Momentum
71
72
Value
41
41
Sentiment
41
45
Setup Bias
Net —
-
Market Cap
-
-
Posture
Defensive
Mixed
Grade position vs CTNM
TECX / CTNM
Grade Position
Below peers
TECX vs. peer average (D vs. B)
19/100
Momentum
71
CTNMValue
41
TECXSentiment
41
CTNMRotation landscape
Peers ranked by the order returned from the peer source, with grades from the API.
Rank
Ticker
Company
Grade
Grade score
vs TECX
CTNM is the first peer returned for this comparison set.